Key opportunities in the UK sleep apnea devices market include leveraging rising demand for efficient healthcare, expanding AI and ML integration for personalized care, and catering to an aging, ...

Resmed is making another strategic investment in U.S.-based manufacturing and distribution, this time in Indianapolis. The move aims to position the company’s inventory of CPAP devices ...

Pacific Sleep Apnea Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...

The ASX lifted by midday on Friday as gold miners glittered, but Origin’s gas stumble left utilities in the dust.

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

(MENAFN- GetNews) Air Voel, a trusted name in sleep therapy solutions and an official distributor of ResMed devices in Canada, is proud to introduce the ResMed AirSense 11 Auto, the latest advancement ...

Resmed reported revenue of $1.9 billion for the first quarter of fiscal year 2026, a 9% increase compared to the same period in 2025.

Despite growing evidence that sleep apnea contributes to cardiovascular disease and can even make it worse, about 50% to 77% of hospitalized patients remain undiagnosed, according to a West Virginia ...

Resmed Inc (($RMD)) announced an update on their ongoing clinical study. Study Overview: ResMed Inc. is conducting a study titled ‘Nyx3 Eye Mask ...

Eight Sleep is rolling out ‘outage mode’ following the Amazon Web Services outage earlier this week which affected its Pod covers. Eight Sleep Pod users reported their smart bed overheating or getting ...

The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...